Benzinga | Sep 1, 2020 07:30AM EDT

Aemetis Receives FDA National Drug Code For OTC Sanitizer Products

Hand Sanitizer and Other Sanitizer Products to be Produced for Consumer Markets and to Fight COVID-19 Pandemic

CUPERTINO, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Aemetis, Inc. (NASDAQ:AMTX), an advanced renewable fuels and biochemicals company that is a producer of high grade sanitizer alcohol, today announced that the Food & Drug Administration (FDA) has issued a National Drug Code (NDC) to Aemetis for the production and marketing of Over The Counter (OTC) sanitizer products.

"This FDA registration is an important step for Aemetis in the production and distribution of blended and packaged sanitizer alcohol products by our wholly-owned subsidiary, Aemetis Health Products," stated Eric McAfee, Chairman and CEO of Aemetis, Inc. "Aemetis is in a unique position as the only large-scale producer of high grade sanitizer alcohol in the Western United States, and we plan to address the ongoing demand for hand sanitizer, alcohol wipes, and other sanitizer products under the Aemetis Health Products brand and on a private label basis."

The global market for hand sanitizer and sanitizer products was approximately $2.9 billion in year 2019, but has grown rapidly in the first half of 2020 due to the global COVID-19 pandemic.